Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Comparison of the Outcome of Patients Protected by the Wearable Cardioverter Defibrillator (WCD) for <90 Wear Days versus ≥90 Wear Days

TOBIAS C. DREHER, IBRAHIM EL-BATTRAWY, SUSANNE RÖGER, STEPHANIE L. ROSENKAIMER, STEFAN GERHARDS, JÜRGEN KUSCHYK, MARTIN BORGGREFE and IBRAHIM AKIN
In Vivo November 2020, 34 (6) 3601-3610; DOI: https://doi.org/10.21873/invivo.12205
TOBIAS C. DREHER
1First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tobias.dreher{at}stud.uni-heidelberg.de
IBRAHIM EL-BATTRAWY
1First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany
2German Centre for Cardiovascular Research (DZHK), Partner Site, Heidelberg/Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SUSANNE RÖGER
1First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany
2German Centre for Cardiovascular Research (DZHK), Partner Site, Heidelberg/Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEPHANIE L. ROSENKAIMER
1First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany
2German Centre for Cardiovascular Research (DZHK), Partner Site, Heidelberg/Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEFAN GERHARDS
1First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany
2German Centre for Cardiovascular Research (DZHK), Partner Site, Heidelberg/Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JÜRGEN KUSCHYK
1First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany
2German Centre for Cardiovascular Research (DZHK), Partner Site, Heidelberg/Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARTIN BORGGREFE
1First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany
2German Centre for Cardiovascular Research (DZHK), Partner Site, Heidelberg/Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IBRAHIM AKIN
1First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Mannheim, Germany
2German Centre for Cardiovascular Research (DZHK), Partner Site, Heidelberg/Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Indications for wearable cardioverter defibrillator (WCD) use.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Comparison of wear days and wearable cardioverter defibrillator (WCD) shock therapy.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Comparison of wear days and device implantation.

Tables

  • Figures
  • Table I.
  • Table II.
  • Table III.
PreviousNext
Back to top

In this issue

In Vivo
Vol. 34, Issue 6
November-December 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of the Outcome of Patients Protected by the Wearable Cardioverter Defibrillator (WCD) for
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Comparison of the Outcome of Patients Protected by the Wearable Cardioverter Defibrillator (WCD) for <90 Wear Days versus ≥90 Wear Days
TOBIAS C. DREHER, IBRAHIM EL-BATTRAWY, SUSANNE RÖGER, STEPHANIE L. ROSENKAIMER, STEFAN GERHARDS, JÜRGEN KUSCHYK, MARTIN BORGGREFE, IBRAHIM AKIN
In Vivo Nov 2020, 34 (6) 3601-3610; DOI: 10.21873/invivo.12205

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Comparison of the Outcome of Patients Protected by the Wearable Cardioverter Defibrillator (WCD) for <90 Wear Days versus ≥90 Wear Days
TOBIAS C. DREHER, IBRAHIM EL-BATTRAWY, SUSANNE RÖGER, STEPHANIE L. ROSENKAIMER, STEFAN GERHARDS, JÜRGEN KUSCHYK, MARTIN BORGGREFE, IBRAHIM AKIN
In Vivo Nov 2020, 34 (6) 3601-3610; DOI: 10.21873/invivo.12205
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Limitations
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Bioelectrical Impedance Analysis in the Diagnosis of Sarcopenia in Oncological Patients: The Sarco-Detect Study
  • Stage-dependent Expression of Autophagy-related Genes in Patients With Knee Osteoarthritis
  • Effects of Short-term High-dose Vitamin D Supplementation on Mineral Homeostasis in Healthy Young Adults
Show more Clinical Studies

Keywords

  • Wearable cardioverter defibrillator (WCD)
  • heart insufficiency
  • Sudden cardiac death
In Vivo

© 2026 In Vivo

Powered by HighWire